Replies to post #20136 on Synaptogenix Inc (SNPX)

[runncoach]

We're not talking 250. We're talking about 75 million at 10 bucks

[Battle Ready]

Wasn't the placebo result a bizarre statistical anomaly??

It seems to me that much more has been learned since the original 2B trial, and not merely pertaining to Alzheimers but importantly other indications, notably MS...

The peer reviewed article suggests a statistically significant favorable response from the drug and then the current trial was designed with all of the learning factored in. We didn't have that going in to the original 2B...

What is the probability that this trial will be successful?? IMHO, the current share price suggests an expectation of less than 1%, I believe the actual probability is substantially higher...